This inventor holds 1 USPTO granted patent. Top assignee: Johns Hopkins University. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Innovations by Marcos Iglesias Lozano
Introduction
Marcos Iglesias Lozano is an accomplished inventor based in Baltimore, MD (US). He has made significant contributions to the field of biomedical engineering, particularly in the development of innovative therapeutic solutions.
Latest Patents
One of his notable patents is titled "Tolerogenic artificial antigen-presenting cells." This patent describes a biodegradable particle that comprises a polyester or polyester blend, a first protein that binds to an immune cell, and a second protein that promotes proliferation and/or activation of immune cells. Additionally, it includes a third soluble protein or small molecule encapsulated within the particle. The second protein is a fusion protein that consists of at least a portion of an antibody and at least a portion of a cytokine, known as an immunocytokine. The patent also outlines methods for treating diseases or conditions, such as autoimmune diseases, by administering the biodegradable particle to the subject. Marcos holds 1 patent in this area.
Career Highlights
Marcos Iglesias Lozano is affiliated with Johns Hopkins University, where he continues to advance his research and innovation in the biomedical field. His work focuses on creating solutions that can significantly impact patient care and treatment methodologies.
Collaborations
Some of his notable coworkers include Jordan J Green and Stephany Yi Tzeng, who collaborate with him on various research projects and innovations.
Conclusion
Marcos Iglesias Lozano exemplifies the spirit of innovation in the biomedical field through his groundbreaking work and patents. His contributions are paving the way for new therapeutic approaches that could transform the treatment of autoimmune diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
